Farxiga Geriatric (65+) School and Activity Considerations

Does Dapagliflozin Require a Different Dose in Adults Over 65?

No age-specific dose reduction is required for dapagliflozin in adults 65 and older. The FDA-approved prescribing information for Farxiga states that pharmacokinetics are not meaningfully altered by age alone, and the standard 10 mg once-daily dose is used across all adult age groups. Renal function, not age, determines dosing eligibility.

Why Age Alone Does Not Change the Dose

Dapagliflozin is renally excreted. The FDA label ties glycemic-control eligibility to an eGFR of at least 45 mL/min/1.73 m², not to a chronological age cutoff. Older adults frequently have lower eGFR values due to normal aging-related nephron loss, so clinicians should check renal function before initiating or continuing therapy, particularly in patients over 75. A 2019 analysis in Diabetes Care confirmed that SGLT2 inhibitor efficacy for HbA1c reduction diminishes as eGFR falls below 60 mL/min/1.73 m², which is a threshold many older adults approach.

eGFR Cutoffs That Matter in Practice

For heart failure and chronic kidney disease (CKD) indications, the eGFR threshold is lower. The DAPA-CKD trial (N=4,304) enrolled patients with eGFR 25 to 75 mL/min/1.73 m² and showed a 39% relative risk reduction in the composite of sustained eGFR decline, end-stage kidney disease, or renal/CV death with dapagliflozin 10 mg vs. Placebo. pubmed.ncbi.nlm.nih.gov/32970396. Older adults with CKD therefore may still qualify for therapy even when glycemic benefit is limited.

Volume Depletion and Hydration in Active Older Adults

Older adults are physiologically predisposed to dehydration. Aging reduces renal concentrating ability, blunts thirst perception, and lowers total body water by roughly 10% to 15% compared with younger adults. Dapagliflozin amplifies urinary glucose and sodium excretion through SGLT2 blockade, adding an osmotic diuretic load on top of an already-stressed fluid-regulatory system. A 2017 systematic review in JAMA Internal Medicine found that SGLT2 inhibitors increased volume depletion events by 1.66-fold (95% CI 1.27 to 2.16) vs. Comparators in pooled trial data.

How Physical Activity Changes the Equation

Exercise accelerates sweat loss and redistributes fluid to working muscles. In a senior who walks 30 minutes daily, attends aqua-aerobics, or participates in a silver-fitness class, the combined urinary and sweat losses may produce symptomatic hypovolemia even when baseline intake appears adequate. The practical target is 500 mL to 750 mL of water in the two hours before sustained physical activity, with ongoing sips of 150 mL to 250 mL every 20 minutes during exercise.

Signs to Watch During Structured Programs

Postural dizziness on standing is the most common early signal. Blood pressure drop of more than 20 mmHg systolic upon standing, defined as orthostatic hypotension per the American Heart Association, warrants immediate rest and fluid replacement. ahajournals.org/doi/10.1161/HYPERTENSIONAHA.119.14184. Instructors at senior fitness programs and community college wellness courses should be informed that a student taking an SGLT2 inhibitor may need to excuse themselves for water breaks more often than peers.

Fall Risk: The SGLT2-Activity Intersection in Seniors

Falls are the leading cause of injury death in adults 65 and older. The CDC reports that approximately 36 million falls occur annually in this age group in the United States, resulting in more than 32,000 deaths per year. cdc.gov/falls/data. Dapagliflozin contributes to fall risk through two separate mechanisms: osmotic diuresis-driven postural hypotension and, in patients with type 1 diabetes (off-label use), potential hypoglycemia when combined with insulin.

What the Farxiga Label Says About Fractures

The FDA prescribing information for dapagliflozin includes a specific warning about bone fracture, noting an imbalance in fracture rates observed in one cardiovascular outcomes trial. accessdata.fda.gov/drugsatfda_docs/label/2023/202293s030lbl.pdf. Although fracture causality remains debated, the American Diabetes Association's 2024 Standards of Care state that clinicians should assess fracture risk before prescribing SGLT2 inhibitors to older adults with low bone mineral density. diabetesjournals.org/care/article/47/Supplement_1/S1/153954.

Activity Modifications That Reduce Fall Events

Several evidence-based steps reduce fall probability without requiring patients to stop dapagliflozin:

• Measure blood pressure lying and standing before each exercise session.
• Increase fluid intake by 250 mL to 500 mL in the 90 minutes before classes or walks.
• Perform balance exercises (single-leg stance, heel-to-toe walking) at least three times per week. A 2019 Cochrane review (54 trials, N=12,283) confirmed that exercise programs reduce fall rate by 23% in community-dwelling older adults. cochranelibrary.com/doi/10.1002/14651858.CD012424.pub2.
• Wear supportive footwear with non-slip soles during aquatic or gym sessions.
• Avoid high-intensity interval training during periods of heat or illness, when dehydration risk peaks.

Exercise Physiology and Dapagliflozin: What Happens During a Workout

During aerobic exercise, circulating insulin drops and glucagon rises, signaling the liver to release glucose. Simultaneously, dapagliflozin continues blocking tubular glucose reabsorption, so more glucose spills into urine. The net effect in a type 2 diabetic senior is modest: blood glucose tends to fall somewhat during moderate activity but rarely reaches hypoglycemic thresholds because dapagliflozin does not directly stimulate insulin secretion. A 2020 study in Diabetes, Obesity and Metabolism found no significant increase in hypoglycemia during structured exercise in patients on dapagliflozin monotherapy.

Resistance Training Considerations

Older adults gain specific metabolic benefits from resistance (strength) training. A program of two to three sessions per week at 60% to 80% of one-repetition maximum preserves lean mass, improves insulin sensitivity, and reduces HbA1c by an estimated 0.3% to 0.5% independently of medication. pubmed.ncbi.nlm.nih.gov/22332093/. When combined with dapagliflozin, the additive glucose-lowering may require reassessment of concurrent sulfonylurea or insulin doses to avoid hypoglycemia from those agents, even if dapagliflozin itself is low-risk for hypoglycemia in isolation.

Prolonged Exercise and Euglycemic DKA Risk

Euglycemic diabetic ketoacidosis (DKA) is a rare but serious complication of SGLT2 inhibitor use, presenting with blood glucose below 250 mg/dL alongside elevated ketones. Prolonged, strenuous exercise (greater than 90 minutes) while fasted and on dapagliflozin has been associated with case reports of euglycemic DKA. The FDA issued a safety communication on this risk in 2015 and updated labeling accordingly. fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-warns-diabetic-ketoacidosis-new-medicines-treat-type-2-diabetes. Seniors training for events such as charity walks, senior Olympics, or cycling tours should consume at least 30 g to 45 g of carbohydrate per hour during exercise lasting beyond 60 minutes.

Senior Learning Environments: Practical Guidance for Programs and Instructors

Adults 65 and older increasingly participate in community college coursework, senior center wellness days, continuing education programs, and structured group fitness. These settings introduce specific logistical challenges for someone managing dapagliflozin therapy.

Timing the Dose Around Class Schedules

Dapagliflozin is taken once daily, with or without food. Urinary frequency peaks in the two to four hours after ingestion due to maximal glucosuria. A senior with a 9 AM fitness class may prefer taking the tablet at 6 AM to allow the peak diuretic effect to pass before exercise begins. Alternatively, taking it with the evening meal shifts peak urinary output to nighttime, reducing inconvenience during daytime programs and lowering the risk of exercise-associated volume loss. Patients should discuss the preferred timing with their prescribing clinician rather than splitting or skipping doses.

Communicating With Program Staff

Senior wellness coordinators are not expected to manage medications, but they can play a supporting role. Patients on dapagliflozin may benefit from sharing the following information with instructors in writing:

• The drug causes increased urination and requires regular water breaks.
• Postural dizziness is a recognized side effect; the student may need to sit down suddenly.
• Genital yeast infections are more common with SGLT2 inhibitors. Shared locker rooms or pool facilities warrant standard hygiene precautions already recommended for all participants.

The ADA's 2024 Standards of Care specifically recommend that care plans for older adults include caregiver and environmental context, which extends to structured activity programs. diabetesjournals.org/care/article/47/Supplement_1/S1/153954.

Hot Weather and Outdoor Classes

Summer walking groups, garden programs, and outdoor tai chi classes present heightened risk. Ambient temperature above 32°C (90°F) accelerates both sweat loss and renal water conservation demands. One practical approach: weigh yourself before and after an outdoor session. Each pound of body weight lost equals approximately 480 mL of fluid that was not replaced. Any loss exceeding 2% of body weight (roughly 1.5 kg in a 75 kg adult) signals a need for more aggressive pre-hydration before the next session.

Cardiovascular Benefits in Older Adults: Why Activity and Dapagliflozin Work Together

The DAPA-HF trial (N=4,744) enrolled adults with heart failure with reduced ejection fraction (HFrEF), mean age 66 years. Dapagliflozin 10 mg reduced the primary composite of worsening heart failure or cardiovascular death by 26% vs. Placebo (hazard ratio 0.74, 95% CI 0.65 to 0.85, P<0.001). nejm.org/doi/10.1056/NEJMoa1911303. Patients on dapagliflozin also reported meaningful improvements in Kansas City Cardiomyopathy Questionnaire scores, reflecting better functional capacity for daily activities.

Physical activity independently reduces cardiovascular event rates. A meta-analysis published in the BMJ (N=180,000 across 35 cohorts) found that 150 minutes per week of moderate-intensity activity reduces cardiovascular mortality by 26%. bmj.com/content/347/bmj.f5555. The combination of structured exercise and dapagliflozin may therefore offer additive protection, though direct head-to-head data comparing exercise plus dapagliflozin vs. Dapagliflozin alone in older adults remain limited.

Functional Capacity and Quality of Life

Older adults who maintain aerobic fitness report fewer diabetes-related functional limitations. The DECLARE-TIMI 58 trial (N=17,160, mean age 63.9 years) showed that patients on dapagliflozin had fewer hospitalized heart failure events, which translates directly to preserved activity capacity. nejm.org/doi/10.1056/NEJMoa1812389. Staying active, even at moderate intensity, is fully compatible with dapagliflozin therapy when the monitoring strategies described above are followed.

Monitoring Parameters for Older Adults on Dapagliflozin Who Exercise Regularly

Routine monitoring should occur at initiation, at 3 months, and every 6 months thereafter. The table below summarizes key parameters and targets for active adults 65 and older.

| Parameter | Frequency | Target or Action Threshold | |---|---|---| | eGFR | Every 6 months | Discontinue for glycemia if <45; continue HF/CKD use per label | | Serum electrolytes | Every 6 months | Sodium <135 mEq/L warrants fluid review | | HbA1c | Every 3 months initially | Individualize target; ADA suggests <8.0% for frail seniors | | Blood pressure (lying/standing) | Each clinic visit | Orthostatic drop >20 mmHg systolic requires intervention | | Weight (hydration screen) | Weekly self-monitoring | Loss >2% body weight in 24 hours prompts clinical review | | Urine/genital symptoms | Each visit | Prompt antifungal treatment if mycotic infection confirmed | | Ketones (point-of-care) | Before and after strenuous activity (>60 min) | Beta-hydroxybutyrate >1.5 mmol/L plus symptoms warrants ED evaluation |

The ADA's geriatric diabetes guidelines recommend targeting HbA1c of 7.0% to 7.5% in healthy older adults and 7.5% to 8.0% in those with intermediate or poor health status, explicitly deprioritizing tight control to reduce hypoglycemia risk. diabetesjournals.org/care/article/47/Supplement_1/S1/153954.

Drug Interactions Relevant to Active Seniors

Older adults commonly take multiple medications. Several combinations increase the risk of volume depletion or electrolyte disturbance when dapagliflozin is added:

• Loop diuretics (furosemide, torsemide): Additive diuresis. A senior on furosemide 40 mg daily plus dapagliflozin 10 mg has a compounded diuretic load. Renal function and blood pressure should be rechecked within two to four weeks of adding dapagliflozin. pubmed.ncbi.nlm.nih.gov/31174035/.
• NSAIDs (ibuprofen, naproxen): Common in active seniors for musculoskeletal pain. NSAIDs reduce renal prostaglandin synthesis, further impairing volume regulation and potentially masking early signs of dehydration. pubmed.ncbi.nlm.nih.gov/29986116/.
• ACE inhibitors and ARBs: Frequently co-prescribed for heart failure or CKD. These agents already lower blood pressure; adding dapagliflozin's modest BP-lowering effect (approximately 2 to 3 mmHg systolic in trial data) may cause clinically relevant hypotension during exercise.
• Insulin or sulfonylureas: Do not cause hypoglycemia on their own with dapagliflozin, but when exercise lowers glucose and dapagliflozin continues excreting it, the risk from insulin or sulfonylureas increases. Dose reduction of the insulin or sulfonylurea may be necessary at exercise program initiation.

Genital Mycotic Infections in Active Older Adults

Dapagliflozin approximately doubles the rate of genital mycotic (yeast) infections compared with placebo in clinical trial data. pubmed.ncbi.nlm.nih.gov/24763149/. The mechanism is direct: persistent glucosuria creates a nutrient-rich local environment for Candida species. For older adults using shared locker rooms, swimming pools, or fitness facilities, standard hygiene measures reduce transmission risk, though yeast infections are not contagious in the ordinary sense.

Postmenopausal women are at higher baseline risk for vaginal candidiasis due to estrogen-deficient vaginal epithelium. Seniors with recurrent infections (three or more per year) should discuss whether dapagliflozin remains the appropriate agent or whether a topical antifungal maintenance strategy is warranted.